EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis

Eleni Moschouri, Gloria Salemme, Adriana Baserga, Andreas Cerny, Ansgar Deibel, Beat Müllhaupt, Marie-Anne Meier, Christine Bernsmeier, Marie Ongaro, Francesco Negro, Marielle Grosjean, Olivier Clerc und 9 weitere

Swiss Medical Weekly · 2024

DOI: 10.57187/s.3698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Swiss Medical Weekly, 2024. Verfasst von Eleni Moschouri und 20 weiteren Autor:innen. Beteiligte Einrichtung: 1Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne. elenimoschouri@gmail.com. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Antiviral Agents, Sustained Virologic Response, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Direct-acting antivirals (DAAs) have revolutionised the management of chronic hepatitis C. We analysed the use of different generations of DAAs over time in Switzerland and investigated factors predictive of treatment failure. METHODS: This retrospective study was conducted within the framework of the Swiss Association for the Study of the Liver and the Swiss Hepatitis C Cohort Study; it included all patients with chronic hepatitis C treated with DAAs between January 2015 and December 2019 at eight Swiss referral centres. RESULTS: A total of 3088 patients were included; 57.3% were male, and the median age was 54 years. Liver cirrhosis was present in 23.9% of the cohort, 87.8% of whom were compensated. The overall sustained virological response (SVR) rate (defined as undetectable HCV RNA at week 12 after the first course of DAA-based treatment) was 96.2%, with an increase over time. The rate of treatment failure dropped from 8.3% in 2015 to 2.5% in 2019. Multivariable analysis revealed that female sex, the use of the latest generation of pangenotypic DAA regimens, Caucasian origin, and genotype (gt) 1 were associated with SVR, whereas the presence of active hepatocellular carcinoma (HCC), gt 3, and increasing liver stiffness were associated with treatment failure. Notably, the presence of active HCC during treatment increased the risk of DAA failure by a factor of almost thirteen. CONCLUSIONS: SVR rates increased over time, and the highest success rates were identified after the introduction of the latest generation of pangenotypic DAA regimens. Active HCC, gt 3 and increasing liver stiffness were associated with DAA failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicAntiviral AgentsSustained Virologic ResponseLiver CirrhosisHumansSwitzerlandMaleFemaleMiddle AgedRetrospective StudiesHepacivirusTreatment FailureGenotypeCarcinoma, HepatocellularLiver NeoplasmsAdult

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • 1Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne. elenimoschouri@gmail.com.
  • . gloriasalemme@libero.it.
  • Epatocentro Ticino, Lugano. lugano@sanacare.ch.
  • Epatocentro Ticino, Lugano. andreas.cerny@hin.ch.
  • Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich. RudolfAnsgar.Deibel@usz.ch.
  • Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich. beat.muellhaupt@usz.ch.

Zitieren

APA

Moschouri, E., Salemme, G., Baserga, A., Cerny, A., Deibel, A., Müllhaupt, B., Meier, M. A., Bernsmeier, C., Ongaro, M., Negro, F., Grosjean, M., Clerc, O., Künzler-Heule, P., Semela, D., Hobi, G., Stickel, F., Mathieu, A., Mdawar-Bailly, E., Faouzi, M., …, & Fraga, M. (2024). Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis. Swiss Medical Weekly. https://doi.org/10.57187/s.3698

Vancouver

Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Müllhaupt B, et al. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis. Swiss Medical Weekly. 2024. doi:10.57187/s.3698

BibTeX
@article{Moschouri2024,
  author = {Moschouri, Eleni and Salemme, Gloria and Baserga, Adriana and Cerny, Andreas and Deibel, Ansgar and Müllhaupt, Beat and Meier, Marie-Anne and Bernsmeier, Christine and Ongaro, Marie and Negro, Francesco and Grosjean, Marielle and Clerc, Olivier and Künzler-Heule, Patrizia and Semela, David and Hobi, Gabriel and Stickel, Felix and Mathieu, Adeline and Mdawar-Bailly, Elise and Faouzi, Mohamed and Moradpour, Darius and Fraga, Montserrat},
  title = {Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis},
  journal = {Swiss Medical Weekly},
  year = {2024},
  doi = {10.57187/s.3698}
}
Kostenlos starten →